HOURIA
BOULAIZ
Investigadora en el periodo 2005-2005
Universidad de Granada
Granada, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Granada (60)
2023
-
Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma
Cancers, Vol. 15, Núm. 14
2020
-
miRNAs as radio-response biomarkers for breast cancer stem cells
Molecular Oncology, Vol. 14, Núm. 3, pp. 556-570
2019
-
Deciphering the mechanism of action involved in enhanced suicide gene colon cancer cell killer effect mediated by gef and apoptin
Cancers, Vol. 11, Núm. 2
-
Melanoma cancer stem-like cells: Optimization method for culture, enrichment and maintenance
Tissue and Cell, Vol. 60, pp. 48-59
2018
-
Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile
Cancer Letters, Vol. 429, pp. 78-88
2017
-
Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism
Expert Reviews in Molecular Medicine, Vol. 19
-
Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity
Scientific Reports, Vol. 7
2016
-
Cancer suicide gene therapy: a patent review
Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 9, pp. 1095-1104
-
Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what’s new?
Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 8, pp. 877-890
2014
-
HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound
Oncotarget, Vol. 5, Núm. 11, pp. 3590-3606
-
Qualitative and quantitative analyses of anatomists' research: Evaluation of multidisciplinarity and trends in scientific production
Scientometrics, Vol. 98, Núm. 1, pp. 447-456
2013
-
Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing
BioMed Research International, Vol. 2013
2012
-
Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells
Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567
-
How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment
Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888
-
Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration
Stem Cells and Development, Vol. 21, Núm. 4, pp. 562-574
-
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 (Springer Netherlands), pp. 157-171
2011
-
Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5- tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine
European Journal of Medicinal Chemistry, Vol. 46, Núm. 9, pp. 3802-3809
-
Development of patents and clinical trials on regenerative therapy: Gene therapy
Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 182-194
-
Nanomedicine: Application areas and development prospects
International Journal of Molecular Sciences, Vol. 12, Núm. 5, pp. 3303-3321
-
Regenerative therapies in cartilage and bone: Current patents, technologies, and emerging applications
Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 134-141